Phenotyping the tumor micro-environment with advanced tissue-based multiplexing assays

The benefits of multiplex immunohistochemistry assays for tissue analysis are numerous. High-level multiplexing, whole slide imaging, workflow compatibility, and spatial analysis are all must-have requirements for effective multiplex IHC solutions. This webinar will provide insight into how Ultivue’s InSituPlex® technology addresses each of these needs and current challenges to enable researchers to unmask the true biology of tissue samples.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Innovation in the cloud: see what artificial intelligence can do for ICMs

esc365

After watching this webinar, participants will understand: how an artificial intelligence algorithm for implantable cardiac monitors is developed and validated; and the reliability of this approach and how it may result in a more efficient hospital workflow.
Watch Now

Advances in HT-SPR, scBCR-seq and RNA-seq

Share a robust method for antigen-specific antibody identification, including current industry advances Help you understand cell types, cell states, and developmental workflows using BCR-seq or scRNA-seq
Watch Now

Single-Cell Electrophysiology and 2-Photon Imaging in Awake Mice with 2D-Locomotion Tracking

workcast

In this webinar, experts present their research utilizing the Mobile Home Cage, an experimental tool which ensures the stability required for high-precision neurophysiological techniques while allowing awake mice to navigate and explore their environment.
Watch Now

Advanced ODT Technologies for Drug Development in Japan and the US

cmicgroup

CMIC Group, the first and largest CRO in Japan with extended services in drug development and GMP manufacturing in the US, Japan and Asia, held a webinar Advanced ODT Technologies for Drug Development in Japan and the US on April 11, 2019.Since its introduction in the 1980s, the market of orally disintegrating tablet (ODT) has grown annually and ODTs are now available in a variety of therapeutic areas, both over-the-counter (OTC) and by prescription. ODT market is projected to reach US$21B in 2023.In this webinar, CMIC and Aprecia experts talked about advanced ODT technologies and its advantages in drug development.
Watch Now

Spotlight

resources